


Searching News Database: AOTI
HSMN NewsFeed - 17 Feb 2023
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
HSMN NewsFeed - 24 Oct 2017
Acutus Medical(R) Receives FDA Clearance for Advanced Cardiac Mapping Technology for Complex Arrhythmias
Acutus Medical(R) Receives FDA Clearance for Advanced Cardiac Mapping Technology for Complex Arrhythmias
HSMN NewsFeed - 18 Jan 2013
St. Jude Medical Receives CE Mark of Next-Generation Cardiac Device for Stroke Prevention
St. Jude Medical Receives CE Mark of Next-Generation Cardiac Device for Stroke Prevention
HSMN NewsFeed - 19 Mar 2012
Cameron Health’s S-ICD(R) System Scheduled for FDA Panel Review on April 26, 2012
Cameron Health’s S-ICD(R) System Scheduled for FDA Panel Review on April 26, 2012
HSMN NewsFeed - 25 Jan 2011
Robert S. (“Bob”) Ward assumes full-time role as Chairman of Emergence Venture Partners, LLC
Robert S. (“Bob”) Ward assumes full-time role as Chairman of Emergence Venture Partners, LLC
HSMN NewsFeed - 24 Aug 2009
Biovail to Acquire Rights to Develop, Commercialize JP-1730/Fipamezole in North America from Santhera
Biovail to Acquire Rights to Develop, Commercialize JP-1730/Fipamezole in North America from Santhera
HSMN NewsFeed - 25 Jan 2008
Independent Clinical Trial Finds HIFU Surgical Ablation Effective in Treating Atrial Fibrillation
Independent Clinical Trial Finds HIFU Surgical Ablation Effective in Treating Atrial Fibrillation
HSMN NewsFeed - 14 May 2007
Questcor Receives FDA Action Letter for H.P. Acthar(R) Gel for Treatment of Infantile Spasms
Questcor Receives FDA Action Letter for H.P. Acthar(R) Gel for Treatment of Infantile Spasms
HSMN NewsFeed - 28 Mar 2007
CryoCath receives FDA approval to expand STOP AF trial to full cohort of patients
CryoCath receives FDA approval to expand STOP AF trial to full cohort of patients
HSMN NewsFeed - 15 Jan 2007
Medtronic Launches Public Awareness Campaign to Address One of the Nation's Leading Causes of Death
Medtronic Launches Public Awareness Campaign to Address One of the Nation's Leading Causes of Death
HSMN NewsFeed - 9 May 2006
Medtronic Begins Landmark Clinical Trial: Cardiac Device Combines Defibrillation and Heart Monitoring
Medtronic Begins Landmark Clinical Trial: Cardiac Device Combines Defibrillation and Heart Monitoring
Additional items found! 34
Members Archive contains
34 additional stories matching:
AOTI
(Password required)
AOTI
(Password required)
